GLOBAL INJECTABLE DRUG DELIVERY MARKET 2019-2028

Lifesciences | Pharmaceuticals

GLOBAL INJECTABLE DRUG DELIVERY MARKET 2019-2028

Market By Device Type, Route Of Administration, End-user, And Region | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The detailed analysis of the global injectable drug delivery market shows that, in terms of revenue, the industry is estimated to grow at a CAGR of 8.66% during the forecasting years 2019-2028. It garnered a revenue of $20.48 billion in 2019, and is expected to accumulate $43.23 billion by 2028. Injectable delivery systems directly inject or administer the drug into the body of the patient apart from the oral route. Initial injection devices consisted of hypodermic needles and syringes. These first-generation devices were motorized and were used to only direct the drug into the body. 

Consequently, there was an increase in the adaptability of the biologics, and the developments in prefilled syringes have supported the growth of the injectable drug delivery market. The significant technological developments related to prefilled syringes include the introduction of needlestick safety-equipped devices, advanced lubrication technology, and the use of multi?chamber syringes. Also, the changes in lifestyle have led to an increased predisposition to diseases. The higher prevalence of autoimmune diseases will ultimately lead to the increased demand for treatments and devices that can provide a better quality of life to the patients.


Report scope can be customized per your requirements. Request For Customization

The study aims to get an overview of the injectable drug delivery market in terms of various factors. Within this report, the market definition and the key insights regarding the injectable drug delivery industry have been discussed. Also, Porter's five forces model, patent analysis, key buying criteria, legal requirement, regulatory framework, and market attractiveness index have been studied in detail.

Market drivers like the increasing geriatric population, technological advancement, and the growing occurrence of autoimmune diseases are driving the injectable drug delivery market growth. However, the industry is facing market restraints, like the high manufacturing cost of the injectable drug delivery systems, which is obstructing the industry growth.

Key opportunities like the development of better injectable systems and an increase in the healthcare expenditure are driving the market growth. However, challenges such as developments in the alternate drug delivery systems and stringent rules are being faced by this market.



Geographies covered in the injectable drug delivery market by region are:

           North America: United States and Canada

           Europe: United Kingdom, Germany, Italy, Russia, Spain, France, and Rest of Europe

           Asia-Pacific: Japan, China, India, ASEAN countries, South Korea, Australia & New Zealand, and Rest of Asia-Pacific

           Latin America: Brazil, Mexico, and Rest of Latin America

           Middle East and Africa: Turkey, Saudi Arabia, South Africa, United Arab Emirates, and Rest of Middle East & Africa

The injectable drug delivery market has been segmented as follows:

           By Device type

o          Pen injector

o          Prefilled syringe

           Plastic-prefilled syringe

           Glass-prefilled syringe

o          Auto injector

o          Needle-free injector

           Gas-based needle-free injector

           Spring-based needle-free injector

           Other needle-free injectors

           By Route of Administration

o          Subcutaneous

o          Intravenous (IV)

o          Intramuscular

o          Other routes of administration

           By End-user

o          Ambulatory care

o          Clinics/physician offices

o          Home-based

o          Hospital

o          Other end-users

The key players engaged in the injectable drug delivery market are Teva Pharmaceuticals, Baxter International Inc, Novo Nordisk A/S, Becton Dickinson and Company (BD), Gerresheimer, Terumo Corporation, Injex, Schott AG, Novartis AG, Eli Lilly and Company, Pfizer Inc, West Pharmaceuticals, Ypsomed Holding AG, Elcam Medical, and Sanofi SA.

The strategic analysis for each of these companies has been covered in detail. The injectable drug delivery market by company profiles helps to dive into the information about the key market players in this industry and how much of a hold they have on the market.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    GLOBAL INJECTABLE DRUG DELIVERY MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANT

2.2.2.   THREAT OF SUBSTITUTE

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   INTENSITY OF COMPETITIVE RIVALRY

2.3. PATENT ANALYSIS

2.4. KEY INSIGHT

2.5. KEY BUYING CRITERIA

2.6. LEGAL REQUIREMENT

2.7. REGULATORY FRAMEWORK

2.8. MARKET ATTRACTIVENESS INDEX

2.9. MARKET DRIVERS

2.9.1.   INCREASING GERIATRIC POPULATION

2.9.2.   TECHNOLOGICAL ADVANCEMENT

2.9.3.   GROWING OCCURRENCE OF AUTOIMMUNE DISEASES

2.10. MARKET RESTRAINTS

2.10.1. HIGH MANUFACTURING COST OF INJECTABLE DRUG DELIVERY SYSTEMS

2.11. MARKET OPPORTUNITIES

2.11.1.  DEVELOPMENT OF BETTER INJECTABLE SYSTEMS

2.11.2.  INCREASE IN HEALTHCARE EXPENDITURE

2.12.  MARKET CHALLENGES

2.12.1.  DEVELOPMENTS IN ALTERNATE DRUG DELIVERY SYSTEMS

2.12.2. STRINGENT REGULATIONS

3.    INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY DEVICE TYPE

3.1. PEN INJECTOR

3.2. AUTO-INJECTOR

3.3. NEEDLE-FREE INJECTOR

3.3.1.   SPRING-BASED NEEDLE-FREE INJECTOR

3.3.2.   GAS-BASED NEEDLE-FREE INJECTOR

3.3.3.   OTHER NEEDLE-FREE INJECTOR

3.4. PREFILLED SYRINGE

3.4.1.   GLASS-PREFILLED SYRINGE

3.4.2.   PLASTIC-PREFILLED SYRINGE

4.    INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY ROUTE OF ADMINISTRATION

4.1. SUBCUTANEOUS

4.2. INTRAMUSCULAR

4.3. INTRAVENOUS (IV)

4.4. OTHER ROUTE OF ADMINISTRATION

5.    INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY END-USER

5.1. CLINICS/ PHYSICIAN OFFICES

5.2. AMBULATORY CARE

5.3. HOSPITAL

5.4. HOME-BASED

5.5. OTHER END-USERS

6.    INJECTABLE DRUG DELIVERY MARKET – REGIONAL OUTLOOK

6.1. NORTH AMERICA

6.1.1.   MARKET BY DEVICE TYPE

6.1.2.   MARKET BY ROUTE OF ADMINISTRATION

6.1.3.   MARKET BY END-USER

6.1.4.   COUNTRY ANALYSIS

6.1.4.1.      UNITED STATES

6.1.4.2.      CANADA

6.2. EUROPE

6.2.1.   MARKET BY DEVICE TYPE

6.2.2.   MARKET BY ROUTE OF ADMINISTRATION

6.2.3.   MARKET BY END-USER

6.2.4.   COUNTRY ANALYSIS

6.2.4.1.      UNITED KINGDOM

6.2.4.2.      GERMANY

6.2.4.3.      FRANCE

6.2.4.4.      ITALY

6.2.4.5.      SPAIN

6.2.4.6.      RUSSIA

6.2.4.7.      REST OF EUROPE

6.3. ASIA-PACIFIC

6.3.1.   MARKET BY DEVICE TYPE

6.3.2.   MARKET BY ROUTE OF ADMINISTRATION

6.3.3.   MARKET BY END-USER

6.3.4.   COUNTRY ANALYSIS

6.3.4.1.      JAPAN

6.3.4.2.      CHINA

6.3.4.3.      AUSTRALIA & NEW ZEALAND

6.3.4.4.      INDIA

6.3.4.5.      SOUTH KOREA

6.3.4.6.      ASEAN COUNTRIES

6.3.4.7.      REST OF ASIA-PACIFIC

6.4. LATIN AMERICA

6.4.1.   MARKET BY DEVICE TYPE

6.4.2.   MARKET BY ROUTE OF ADMINISTRATION

6.4.3.   MARKET BY END-USER

6.4.4.   COUNTRY ANALYSIS

6.4.4.1.      BRAZIL

6.4.4.2.      MEXICO

6.4.4.3.      REST OF LATIN AMERICA

6.5. MIDDLE EAST AND AFRICA

6.5.1.   MARKET BY DEVICE TYPE

6.5.2.   MARKET BY ROUTE OF ADMINISTRATION

6.5.3.   MARKET BY END-USER

6.5.4.   COUNTRY ANALYSIS

6.5.4.1.      SAUDI ARABIA

6.5.4.2.      TURKEY

6.5.4.3.      UNITED ARAB EMIRATES

6.5.4.4.      SOUTH AFRICA

6.5.4.5.      REST OF MIDDLE EAST & AFRICA

7.    COMPANY PROFILES

7.1. BAXTER INTERNATIONAL INC

7.2. BECTON DICKINSON AND COMPANY (BD)

7.3. ELCAM MEDICAL

7.4. ELI LILLY AND COMPANY

7.5. GERRESHEIMER

7.6. INJEX

7.7. NOVARTIS AG

7.8. NOVO NORDISK A/S

7.9. PFIZER INC

7.10.  SANOFI SA

7.11.  SCHOTT AG

7.12.  TERUMO CORPORATION

7.13.  TEVA PHARMACEUTICALS

7.14. WEST PHARMACEUTICALS

7.15.   YPSOMED HOLDING AG

8.    RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE  1       GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY REGION, 2019-2028 ($ MILLION)

TABLE  2       GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2028 ($ MILLION)

TABLE  3       DIFFERENT TYPES OF INSULIN PEN INJECTORS

TABLE  4       MARKETED NEEDLE-FREE INJECTORS PRODUCTS

TABLE  5       GLOBAL NEEDLE-FREE INJECTOR BY TYPE, 2019-2028 ($ MILLION)

TABLE  6       LYOPHILIZED DRUGS WHICH ARE USED IN PREFILLED SYRINGE

TABLE  7       GLOBAL PREFILLED SYRINGE, BY TYPE, 2019-2028 ($ MILLION)

TABLE  8       GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 ($ MILLION)

TABLE  9       GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE  10     GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY REGION, 2019-2028 ($ MILLION)

TABLE  11     NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2028 ($ MILLION)

TABLE  12     NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 ($ MILLION)

TABLE  13     NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE  14     NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE  15     EUROPE INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2028 ($ MILLION)

TABLE  16     EUROPE INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 ($ MILLION)

TABLE  17     EUROPE INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE  18     EUROPE INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE  19     ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2028 ($ MILLION)

TABLE  20     ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 ($ MILLION)

TABLE  21     ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE  22     ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE  23     LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2028 ($ MILLION)

TABLE  24     LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 ($ MILLION)

TABLE  25     LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE  26     LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE  27     MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2028 ($ MILLION)

TABLE  28     MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 ($ MILLION)

TABLE  29     MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE  30     MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)       

List of Figures

FIGURE  1     GLOBAL INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  2     KEY BUYING IMPACT ANALYSIS

FIGURE  3     GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY PEN INJECTOR, 2019-2028 ($ MILLION)

FIGURE  4     GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY AUTO-INJECTOR, 2019-2028 ($ MILLION)

FIGURE  5     GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY NEEDLE-FREE INJECTOR, 2019-2028 ($ MILLION)

FIGURE  6     GLOBAL NEEDLE-FREE INJECTOR MARKET, BY SPRING-BASED NEEDLE-FREE INJECTOR, 2019-2028 ($ MILLION)

FIGURE  7     GLOBAL NEEDLE-FREE INJECTOR MARKET, BY GAS-BASED NEEDLE-FREE INJECTOR, 2019-2028 ($ MILLION)

FIGURE  8     GLOBAL NEEDLE-FREE INJECTOR MARKET, BY OTHER NEEDLE-FREE INJECTOR, 2019-2028 ($ MILLION)

FIGURE  9     GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY PREFILLED, 2019-2028 ($ MILLION)

FIGURE  10  GLOBAL PREFILLED SYRINGE MARKET, BY GLASS-PREFILLED SYRINGE, 2019-2028 ($ MILLION)

FIGURE  11  GLOBAL PREFILLED SYRINGES MARKET, BY PLASTIC-PREFILLED SYRINGE, 2019-2028 ($ MILLION)

FIGURE  12  GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY SUBCUTANEOUS, 2019-2028 ($ MILLION)

FIGURE  13  GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY INTRAMUSCULAR, 2019-2028 ($ MILLION)

FIGURE  14  GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY INTRAVENOUS, 2019-2028 ($ MILLION)

FIGURE  15  GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY OTHER ROUTE OF ADMINISTRATION, 2019-2028 ($ MILLION)

FIGURE  16  GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY CLINICS/PHYSICIAN OFFICES, 2019-2028 ($ MILLION)

FIGURE  17  GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY AMBULATORY CARE, 2019-2028 ($ MILLION)

FIGURE  18  GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY HOSPITAL, 2019-2028 ($ MILLION)

FIGURE  19  GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY HOME-BASED, 2019-2028 ($ MILLION)

FIGURE  20  GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY OTHER END-USER, 2019-2028 ($ MILLION)

FIGURE  21  UNITED STATES INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  22  CANADA INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  23  UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  24  GERMANY INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  25  FRANCE INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  26  ITALY INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  27  SPAIN INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  28  RUSSIA INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  29  REST OF EUROPE INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  30  JAPAN INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  31  CHINA INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  32  AUSTRALIA & NEW ZEALAND INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  33  INDIA INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  34  SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  35  ASEAN COUNTRIES INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  36  REST OF ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  37  BRAZIL INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  38  MEXICO INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  39  REST OF LATIN AMERICA INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  40  SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  41  TURKEY INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  42  UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  43  SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  44  REST OF MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;